Speakers | 9th MASH Drug Development Summit

2025 Speakers

2025 Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 9th MASH Drug Development Summit.

Belle Van Rosmalen

Director, Medical Development

Eli Lilly

Caleb Roberts

Vice President, Business Development

Antaros Medical

Cynthia Arbeeny

CSO

Mitotherapeutix

Cynthia Lebeaupin

Senior Scientist, Inflammation & Immunology R&D

Pfizer

Erik Tillman

Director, Translational Biology and Pharmacology

Akero Therapeutics

Hank Mansbach

Chief Medical Officer

89 Bio

Jen-Chieh Chuang

Director, Translational Biomarker Lead, Liver Diseases

Takeda Pharmaceuticals

Kavita Juneja

VP Clin Dev

Corcept Therapeutics

Kevin Hart

Associate Director - Scientific Research Fellow

Pfizer

Marie O’Farrell

Senior Vice President - Research & Development

Sagimet Biosciences

Oliver Yoa-Pu Hu

Scientific Board Member

Sinew Pharma

PATRICE MIMCHE

Associate Professor

Indiana University

Rebecca Taub

Founder & Director

Madrigal

Remi Laberge

CTO

Arda Therapeutics

Saheli Chowdhury

Postdoctoral Research Scientist

Columbia University

Sharon Jaycox

Director

Global Liver Institute

MASH Drug Development Summit - Stanley Watowich

Stan Watowich

Founder & Chief Executive Officer

Ridgeline Therapeutics

Wen-Wei Tsai

Senior Director

Sagimet Biosciences

Winston Dunn

Professor

University of Kansas Medical Center

Zoltan Derdak

Director - Medical

Takeda Pharmaceuticals

2025 Event Guide

Partner

Returning 2026

2025 Speakers

2025 Expert Speaker Faculty

Belle Van Rosmalen

Caleb Roberts

Cynthia Arbeeny

Cynthia Lebeaupin

Erik Tillman

Hank Mansbach

Jen-Chieh Chuang

Kavita Juneja

Kevin Hart

Marie O’Farrell

Oliver Yoa-Pu Hu

PATRICE MIMCHE

Rebecca Taub

Remi Laberge

Saheli Chowdhury

Sharon Jaycox

Stan Watowich

Wen-Wei Tsai

Winston Dunn

Zoltan Derdak

OUR CONTACT DETAILS

JOIN OUR TEAM

ABOUT US

EXPLORE OUR PRODUCTS

SEARCH